Article Details

Cantargia : BioInvent and Cantargia sign manufacturing agreement for monoclonal antibody CAN10

Retrieved on: 2020-11-26 07:30:00

Tags for this article:

Click the tags to see associated articles and topics

Cantargia : BioInvent and Cantargia sign manufacturing agreement for monoclonal antibody CAN10. View article details on hiswai:

Excerpt

CAN10 is fully humanized <b>monoclonal antibody</b> targeting IL1RAP. CAN10 has been designed to block the signalling of the inflammatory cytokines IL-1 ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up